Supporting Prescribing in Irish Primary Care: General Practice Pharmacist Study

Royal College of Surgeons, Ireland

Status: Completed

Conditions: Polypharmacy; Multimorbidity

Treatments: Other: PROM Study; Other: Main Study

Study type: Interventional

Funder types: Other

Identifiers

NCT04326062

GPP2071

Details and patient eligibility

About

The aim of this pilot study is to develop and test an intervention (defined as the General Practice Pharmacist [GPP] intervention) involving pharmacists working with General Practitioners (GPs) to optimise prescribing in Ireland. The study will determine the costs and potential effectiveness of the GPP intervention and, through engagement with key stakeholders, will explore the potential for an RCT of the GPP intervention in Irish general practice settings.

Full description

Improving the quality and safety of prescribing for people with multiple chronic conditions and multiple medicines is a challenge for General Practitioners (GPs) and consequently, there has been an increased emphasis on ways to support GPs throughout this process. The integration of pharmacists into the general practice team is one approach being explored internationally and studies have shown that pharmacists, working as part of the general practice team, have influenced the safety and quality of prescribing. However, the evidence base is weak as there have been few high quality randomised controlled trials (RCTs) conducted and a range of modest effect sizes reported. Moreover, it is unclear whether such interventions can result in clinically significant improvements in patient outcomes. In Ireland, pharmacists are not integrated into general practice teams, therefore the feasibility of the integration of pharmacists into general practice warrants further exploration in the Irish primary care setting, prior to evaluation in a full scale RCT. The aim of this study is to develop and pilot test an intervention involving pharmacists, working within GP practices, to optimise prescribing in Ireland, which has a mixed public and private primary healthcare system.

Enrollment: 100 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for primary care practices:

• ≥1000 older patients (aged ≥65 years) on their patient panel.

Inclusion criteria for patients:

• Aged ≥65 years
• Taking ≥10 repeat medications
• Able to attend their primary care practice and participate in data collection.

Exclusion Criteria for patients:

• Psychiatric or psychological morbidity or cognitive impairment sufficient to impair the provision of informed consent
• Life-limiting illness likely to lead to death or major disability during the study follow-up period
• Patients who have already had a medication review/interacted with the pharmacist during the study period

Trial design

Primary purpose: Health Services Research

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Main Study

Experimental group

Description:

A pharmacist will join the practice team for six months.

Treatment:

Other: Main Study

PROM Study

Experimental group

Description:

A nested Patient Reported Outcome Measure (PROM) study will be undertaken during month four and five of the six-month intervention period to explore the impact of the intervention in older adults (aged ≥65 years).

Treatment:

Other: PROM Study